Sponsor or institution
Clinical trials and research at Vir Biotechnology, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Vir Biotechnology, Inc. that are recruiting, at sites in 5 countries (most in Australia (2), United States (2), France (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
Evaluating VIR-5525 and its combination with Pembrolizumab for advanced solid tumors
This study is testing a new treatment called VIR-5525, alone and with another drug called pembrolizumab, to see if it can help people with advanced solid tumors that have a specific protein called EGFR.
-
Evaluating AMX-818 and Pembrolizumab for HER2-Expressing Cancers
This study is testing a new treatment called AMX-818, alone and with another drug called pembrolizumab, to see if it helps adults with advanced HER2-expressing cancers.
Quick answers
How many clinical trials run by Vir Biotechnology, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Australia (2 trials), United States (2 trials), France (1 trial), Portugal (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.